Retinal Biologics Market to Witness Promising Growth Opportunities by 2026-2035
The global retinal biologics market is currently valued at approximately USD 25.65 billion and is projected to reach USD 57.47 billion by 2035, representing a CAGR of 7.61%. Macular degeneration currently accounts for the largest disease-indication segment, while diabetic retinopathy is expected to provide significant future growth opportunities.
For more details on the market, please visit the following URL: https://www.rootsanalysis.com/....reports/retinal-biol
Gusto
Magkomento
Ibahagi
